There are numerous medical and surgical procedures in which it is desirable to cut and remove a strip of tissue of controlled width from the body of a human or veterinary patient. For example, it may sometimes be desirable to form an incision of a controlled width (e.g., an incision that is wider than an incision made by a typical scalpel or cutting blade) in the skin, mucous membrane, tumor, organ or other tissue or a human or animal. Also, it may sometimes desirable to remove a strip or quantity of tissue from the body of a human or animal for use as a biopsy specimen, for chemical/biological analysis, for retention or archival of DNA identification purposes, etc. Also, some surgical procedures require removal of a strip of tissue of a known width from an anatomical location within the body of a patient.
One surgical procedure wherein a strip of tissue of a known width is removed from an anatomical location within the body of a patient is an ophthalmological procedure used to treat glaucoma. This ophthalmological procedure is sometimes refered to as a goniectorny. In a goniectorny procedure, a device that is operative to cut or ablate a strip of tissue of approximately 2-10 mm in length and about 50-200 μm in width is inserted into the anterior chamber of the eye and used to remove a full thickness strip of tissue from the trabecular meshwork. The trabecular meshwork is a loosly organized, porous network of tissue that overlies a collecting canal known as Schlemm's canal A fluid, known as aqueous humor, is continually produced in the anterior chamber of the eye. In normal individuals, aqueous humor flows through the trabecular meshwork, into Shlemm's Canal and out of the eye through a series of ducts. In patients who suffer from glaucoma, the drainage of aqueous humor from the eye may be impared by elevated flow resistance through the trabecular meshwork, thereby resulting in an increase in intreoccular pressure. The goniectomy procedure can restore normal drainage of aqueous humor from the eye by removing a full thickness segment of the trabecular meshwork, thus allowing the aqueous humor to drain through the open area from which the strip of trabecular meshwork has been removed. The goniectomy procedure and certain prior art instruments useable to perform such procedure are described in U.S. patent application Ser. No. 10/052,473 published as No. 2002/011608A1 (Baerveldt), the entirety of which is expressly incorporated herein by reference.
At present there remains a need in the art for the development of simple, inexpensive and accurate instruments useable to perform the goniectomy procedure as well as other procedures where it is desired to remove a strip of tissue from a larger mass of tissue.
The present invention provides a device for cutting a strip of tissue of approximate width W from a mass of tissue. The device generally comprises a) an elongate cutting tube that has a distal end and a lumen that opens through an opening in the distal end and b) first and second cutting edges formed on generally opposite edges of the distal end of the cutting tube and separated by a distance D. The cutting tube is advanceable through tissue such that the first and second cutting edges will cut a strip of tissue having approximate width W, wherein the approximate width W is approximately equal to the distance between the first and second cutting edges. In some embodiments, the strip of tissue may be aspirated or otherwise removed through the lumen of the cutter tube. In some embodiments, the device may include apparatus useable to sever (e.g., transversely cut or transect) the strip of tissue when the strip of tissue has reached a desired length.
Further in accordance with the invention there is provided a method for cutting a strip of tissue of width W from a tissue mass. This method generally comprises the steps of a) providing a device that comprises i) an elongate cutting tube that has a distal end and a lumen that opens through an opening in the distal end and ii) first and second cutting edges formed on generally opposite edges of the distal end of the cutting tube and separated by a distance D that is approximately equal to the width W of the strip of tissue to be cut; and b) advancing the distal end of the cutting tube through the mass of tissue such that the first and second cutting edges cut a strip of tissue of approximate width W. Further aspects and elements of the invention will be understood by those of skill in the art upon reading the detailed description of specific examples set forth herebelow.
The following detailed description, and the drawings to which it refers, are provided for the purpose of describing and illustrating certain preferred embodiments or examples of the invention only, and no attempt has been made to exhaustively describe all possible embodiments or examples of the invention. Thus, the following detailed description and the accompanying drawings shad not be construed to limit, in any way, the scope of the claims recited in this patent application and any patent(s) issuing therefrom.
One example of a needle cutter device 10 of the present invention is shown in
One or more bends or curves may optionally be formed in the cutting tube 14 to facilitate its use for its intended purpose. For example, in the embodiment of the device 10 shown in
As shown in
The device 10 may optionally include a second lumen. Such second lumen may be used for infusion of fluid through the device 10 or for other purposes. In the embodiment shown in
In some embodiments, the device 10 may be equipped with severing apparatus for severing (e.g., transversely cutting or transecting) the strip ST of tissue to fully excise or detach the strip ST of tissue from the remaining tissue mass and/or from the body of a human or animal subject. Such severing apparatus may comprise any suitable type of tissue cutter such as a blade, scissor, guillotine, electrode(s), laser, energy emitting tissue cutter, mechanical tissue cutter, etc.
In some embodiments of the device 10, the cutting edges 20, 22 may be heated such that they will cauterize as the cut. As those of skill in the art will appreciate, such heating of the cutting edges 20, 22 may be accomplished by placement of electrode(s) near the cutting edges 20, 22 such that, when the electrode(s) is/are energized, the cutting edges 20, 22 will become heated to a temperature suitable for the desired cauterization function.
The needle cutter device 10 of the present invention may optionally be used as part of a system 12, as shown in
The device 10 may be provided as a pre-sterilized, single-use disposable probe or tip that is attachable to a standard surgical irrigation/aspiration handpiece such as that commercially available as The Rhein I/A Tip System from Rhein Medical, Inc., Tampa, Fla. After the device 10 has been attached to the handpiece, it may be connected to any or all of the electrosurgical generator module 76, aspiration pump module 74 and the source of irrigation fluid 72, as shown. Thus, the device 10 may be fully equipped for irrigation, aspiration, and electrosurgical capabilities, as described herein.
The device 10 and system 12 are useable to perform a variety of procedures wherein it is desired to form an incision or opening of a desired width or to remove, from a mass of tissue, a strip ST of tissue of a desired width.
One particular procedure that may be performed to treat glaucoma, using the device 10 and system 12 of the present invention, is a goniectomy. As explained herein a goniectomy procedure is an ab interno surgical procedure wherein a sector of the trabecular meshwork is removed from the eye of the patient to facilitate drainage of aqueous humor from the anterior chamber of the eye through Schlemm's Canal and the associated collector channels, thereby relieving elevated intraocular pressure.
To perform a goniectomy procedure using the device 10, first a small incision is made in the cornea at about 3 o'clock in the left eye, or at about 9 o'clock in the right eye. A 1.5 mm slit knife may be used to make this incision.
The device 10 is attached to the source of irrigation fluid 72 (e.g, basic balanced salt solution) such that irrigation fluid will flow through lumen 19 of the outer tube 16 and out of outflow aperture 11. The device 10 is then inserted through the incision and into the anterior chamber of the eye (with irrigation flowing). In some cases, during the insertion of the device 10, the source of irrigation fluid 72 may initially connected to the device such that the irrigation fluid will flow through the lumen 27 of the cutter tube 14. In this manner, irrigation fluid will begin to infuse into the anterior chamber of the eye as soon as the distal end of the cutter tube 14 has entered the anterior chamber, rather than being delayed until the larger outer tube 16 and aperture 11 have been advanced through the incision and into the anterior chamber. By this alternative approach, irrigation fluid may be caused to flow out of the distal end of the cutter tube 14 as the device 10 is being inserted, thereby spreading or opening the incision by hydraulic force while in addition increasing the fluid pressure in the anterior chamber. Such spreading or opening of the incision may facilitate advancement of the larger diameter outer tube 16 through the incision. Pressurizing the fluid in the anterior chamber causes the anterior chamber to deepen and may facilitate maneuvering of device 10 within the anterior chamber. In cases where this alternative approach is used, the source of infusion fluid 72 may be disconnected from lumen 27 of the cutter tube 14 after the device 10 has been inserted into the anterior chamber and, thereafter, the infusion fluid source 72 may be reconnected to lumen 19 of outer tube 16 such that infusion fluid will flow out of aperture 11. Negative pressure (e.g., via aspiration pump module 74) may then be applied to lumen 27 of the cutter tube 14 so as to aspirate fluid and debris through lumen 27 as shown in
A lens device (e.g., Ocular Swan-Jacob Autoclavable Gonioprism, Model OSJAG, Ocular Instruments Inc., Bellevue, Wash.) may be positioned on the anterior aspect of the eye to enable the physician to clearly visualize the angle of the eye where the segment of trabecular meshwork is to be removed. Under direct visualization, the device 10 is advanced until the distal tip of the cutter tube 14 is positioned adjacent to the trabecular meshwork at the location where the strip ST is to be removed. Thereafter, the protruding tip 24 is advanced through the trabecular meshwork and into Schlemm's Canal.
The device 10 is then advanced along Schlemm's Canal, thereby causing the cutting edges 20, 22 to cut a strip of the trabecular meshwork, thereby creating an opening through which aqueous humor may drain from the anterior chamber of the eye.
After a strip of tissue of the desired length (e.g., about 2-10 mm) has been cut by the lateral cutting edges 20, 22, any optional tisue severing apparatus (e.g., electrode(s) 40 may be used (if present) to transect or sever the strp ST of tissue thereby disconnecting it from the patient's body and allowing it to be aspirated or drawn into or through lumen 27.
Thereafter, the aspiration is stopped, the device 10 is removed from the eye, and the infusion is stopped.
Following completion of the surgery, aqueous humor will drain from the anterior chamberthrough the opening that was created by removal of the strip of tissue from the trabecular meshwork TM.
Although the invention has been described above with respect to certain embodiments and examples, it is to be appreciated that such embodiments and examples are non-limiting and are not purported to define all embodiments and examples of the invention. Indeed, those of skill in the art will recognize that various modifications may be made to the above-described embodiments and examples without departing from the intended spirit and scope of the invention and it is intended that all such modifications be included within the scope of the following claims.
This application is a division of U.S. patent application Ser. No. 13/159,356 filed Jun. 13, 2011 currently abandoned which is a division of U.S. patent application Ser. No. 10/560,267 filed May 11, 2006 and issued as U.S. Pat. No. 7,959,641 on Jun. 14, 2011, which is a 35 U.S.C. §371 national stage of PCT International Patent Application No. PCT/US2004/018488 filed Jun. 10, 2004, which claims priority to U.S. Provisional Patent Application No. 60/477,258 timed on Jun. 10, 2003, the entire disclosure of each such prior patent and application being expressly incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3294085 | Wallace | Dec 1966 | A |
3882872 | Douvas et al. | May 1975 | A |
4501274 | Skjaerpe | Feb 1985 | A |
4689040 | Thompson | Aug 1987 | A |
4706669 | Schlegel | Nov 1987 | A |
4753234 | Martinez | Jun 1988 | A |
4759746 | Straus | Jul 1988 | A |
4841984 | Armeniades et al. | Jun 1989 | A |
4900300 | Lee | Feb 1990 | A |
4955883 | Nevyas et al. | Sep 1990 | A |
4955887 | Zirm | Sep 1990 | A |
5019035 | Missirlian et al. | May 1991 | A |
5112299 | Pascaloff | May 1992 | A |
5123904 | Shimomura et al. | Jun 1992 | A |
5269782 | Sutter | Dec 1993 | A |
5284472 | Sussman et al. | Feb 1994 | A |
5431646 | Vassiliadis et al. | Jul 1995 | A |
5458596 | Lax et al. | Oct 1995 | A |
5540706 | Aust et al. | Jul 1996 | A |
5569283 | Green et al. | Oct 1996 | A |
5681282 | Eggers et al. | Oct 1997 | A |
5733297 | Wang | Mar 1998 | A |
5755716 | Garito et al. | May 1998 | A |
5807277 | Swaim | Sep 1998 | A |
5843106 | Heisler | Dec 1998 | A |
5885279 | Bretton | Mar 1999 | A |
5922003 | Anctil et al. | Jul 1999 | A |
5957881 | Peters et al. | Sep 1999 | A |
5957914 | Cook et al. | Sep 1999 | A |
5964777 | Drucker | Oct 1999 | A |
6004199 | Habenicht et al. | Dec 1999 | A |
6068629 | Haissaguerre | May 2000 | A |
6217598 | Berman et al. | Apr 2001 | B1 |
6283961 | Underwood et al. | Sep 2001 | B1 |
6290699 | Hall et al. | Sep 2001 | B1 |
6293957 | Peters et al. | Sep 2001 | B1 |
6382974 | Garfinkel | May 2002 | B1 |
6388043 | Langer et al. | May 2002 | B1 |
6419684 | Heisler et al. | Jul 2002 | B1 |
6428539 | Baxter et al. | Aug 2002 | B1 |
6432104 | Durgin et al. | Aug 2002 | B1 |
RE38018 | Anctil et al. | Mar 2003 | E |
6720402 | Langer et al. | Apr 2004 | B2 |
6759481 | Tong | Jul 2004 | B2 |
6979328 | Baerveldt et al. | Dec 2005 | B2 |
7244256 | DeCesare et al. | Jul 2007 | B2 |
7604663 | Reimink et al. | Oct 2009 | B1 |
7632303 | Stalker et al. | Dec 2009 | B1 |
7648591 | Furst et al. | Jan 2010 | B2 |
7785321 | Baerveldt et al. | Aug 2010 | B2 |
7842034 | Mittelstein et al. | Nov 2010 | B2 |
7935131 | Anthamatten et al. | May 2011 | B2 |
7955387 | Richter | Jun 2011 | B2 |
7959641 | Sorensen et al. | Jun 2011 | B2 |
8038923 | Berger et al. | Oct 2011 | B2 |
8147424 | Kassab et al. | Apr 2012 | B2 |
20010053873 | Schaaf et al. | Dec 2001 | A1 |
20020002372 | Jahns et al. | Jan 2002 | A1 |
20020038129 | Peters et al. | Mar 2002 | A1 |
20020111608 | Baerveldt et al. | Aug 2002 | A1 |
20030208217 | Dan | Nov 2003 | A1 |
20040204732 | Muchnik | Oct 2004 | A1 |
20040210245 | Erickson et al. | Oct 2004 | A1 |
20050159767 | Adams et al. | Jul 2005 | A1 |
20060106370 | Baerveldt et al. | May 2006 | A1 |
20060149194 | Conston et al. | Jul 2006 | A1 |
20060212060 | Hacker et al. | Sep 2006 | A1 |
20060241580 | Mittelstein et al. | Oct 2006 | A1 |
20070010812 | Mittelstein et al. | Jan 2007 | A1 |
20070073275 | Conston et al. | Mar 2007 | A1 |
20070276420 | Sorensen et al. | Nov 2007 | A1 |
20090248141 | Shandas et al. | Oct 2009 | A1 |
20090287233 | Huculak | Nov 2009 | A1 |
20110077626 | Baerveldt et al. | Mar 2011 | A1 |
20110230877 | Huculak et al. | Sep 2011 | A1 |
20120123533 | Shiuey | May 2012 | A1 |
20150045820 | Kahook | Feb 2015 | A1 |
Number | Date | Country |
---|---|---|
0073803 | Mar 1983 | EP |
1455698 | Sep 2004 | EP |
1615604 | Jan 2006 | EP |
2303203 | Apr 2011 | EP |
46-25677 | Sep 1971 | JP |
1020040058309 | Mar 2004 | KR |
WO 9117793 | Nov 1991 | WO |
WO 9827876 | Jul 1998 | WO |
WO0178631 | Oct 2001 | WO |
WO 02056805 | Jul 2002 | WO |
WO03045290 | Jun 2003 | WO |
WO2004093761 | Nov 2004 | WO |
WO2004110501 | Dec 2004 | WO |
WO2009140185 | Nov 2009 | WO |
Entry |
---|
Minckler et al “clinical results with the trabesctome, a novel surgical device for treatment of open angle glaucoma” trans am opthalmol soc/ vol. 104/ 2006. |
Ting, J. L. M. et al., (2012) “Ab interno trabeculectomy: Outcomes in exfoliation versus primary open-angle glaucoma,” J Cataract. Refract. Surg. 38(2),315-323. |
Francis, B. A. et al., (2006) “Ab interno trabeculectomy: development of a novel device (Trabectome) and surgery for open-angle glaucoma,” J Glaucoma 15(1), 68-73. |
Minckler, D. S. et al., (2005) “Clinical Results with the Trabectome for Treatment of Open-Angle Glaucoma,” Ophthalmology 112(6), 962-967. |
Tan, Yar-Li, et al., “Postoperative Complications after Glaucoma Surgery for Primary Angle-Closure Glaucoma vs Primary Open-Angle Glaucoma,” Arch Ophthalmol. 2011; 129(8), pp. 987-992. |
Johnson, Douglas H. et al., “Human Trabecular Meshwork Organ Culture. A New Method.” Invest. Ophthalmol. Vis. Sci. 28(6),945-953, 1987. |
Quigley, H. A. and Broman, A. T., (2006) “The number of people with glaucoma worldwide in 2010 and 2020,” Br. J Ophthalmol. 90(3),262-267. |
Jacobi, P. C. et al., (1999) “Goniocurettage for removing trabecular meshwork: clinical results of a new surgical technique in advanced chronic open-angle glaucoma,” Am. J Ophthalmol. 127(5),505-510. |
Pantcheva, M. B. and Kahook, M. Y., (2010) “Ab Interno Trabeculectomy,” Middle East African Journal of Ophthalmology 17(4), 287-289. |
Seibold, L. K. et al., (2013) “Preclinical Investigation of Ab Interno Trabeculectomy Using a Novel Dual-Blade Device,” Am. J Ophthalmol. 155(3), 524-529.e522. |
Anderson, D.R., (1983) “Trabeculotomy compared to goniotomy for glaucoma in children,” Ophthalmology 90 (7),805-806. |
Grant, W., (1963) “Experimental aqueous perfusion in enucleated human eyes,” Arch.Ophthalmol. 69(6), 783-801. |
Grant, W. M., (1951) “Clinical measurements of aqueous outflow,” AMA Archives of Ophthalmology 46(2), 113-131. |
Herschler, J. and Davis, E. B., (1980) “Modified goniotomy for inflammatory glaucoma. Histologic evidence for the mechanism of pressure reduction,” Arch. Ophthalmol. 98(4), 684-687. |
Jea, S. Y. et al., (2012) “Ab Interno Trabeculectomy Versus Trabeculectomy for Open Angle Glaucoma,” Ophthalmology 119(1), 36-42. |
Luntz, M. H. and Livingston, D. G., (1977) “Trabeculotomy ab externo and trabeculectomy in congenital and adult-onset glaucoma,” Am. J Ophthalmol. 83(2), 174-179. |
US Patent Office Action dated Sep. 29, 2009 in related U.S. Appl. No. 10/560,267, filed May 11, 2006. |
US Patent Office Action dated Mar. 12, 2010 in related U.S. Appl. No. 10/560,267, filed May 11, 2006. |
Jacobi, Philipp C., et al. “Technique of Goniocurettage: A Potential Treatment for Advanced Chronic Open Angle Glaucoma,” British Journal of Ophthalmology, 1997; 81, pp. 302-307. |
Soohoo, Jeffrey R., et al. “Ab Inferno Trabeculectomy in the Adult Patient,” Middle East African Journal of Ophthalmology, vol. 22, No. 1, Jan.-Mar. 2015, pp. 25-29. |
Number | Date | Country | |
---|---|---|---|
20140379015 A1 | Dec 2014 | US |
Number | Date | Country | |
---|---|---|---|
60477258 | Jun 2003 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13159356 | Jun 2011 | US |
Child | 14481754 | US | |
Parent | 10560267 | US | |
Child | 13159356 | US |